AG120,Ivosidenib CAS No.:1448347-49-6

,

As a manufacturer located in China, we are proud to offer one of our newest and most innovative products to merchants from all over the world – AG120, also known as Ivosidenib. This is a groundbreaking pharmaceutical, designed to help those with Acute Myeloid Leukemia (AML) who have a particular genetic mutation. With its unique chemical structure and selective inhibition of mutated IDH1 enzymes, Ivosidenib offers a powerful new avenue for treating these patients, and we are thrilled to be on the forefront of this life-changing technology.

One of the key factors that makes Ivosidenib so promising is its ability to selectively target and bind to mutated IDH1 enzymes, while leaving normal, healthy cells in the body unaffected. This makes Ivosidenib a potentially game-changing therapy for patients who have this genetic mutation and who may have few other effective treatment options otherwise. And as a manufacturer, we pride ourselves on producing high-quality, pure Ivosidenib that has passed rigorous quality-control measures at every stage of the production process.

We take great care to ensure that every batch of Ivosidenib we produce meets the highest standards of purity and efficacy, providing our merchant partners with a product they can trust and have confidence in. And because we are based in China, we are able to offer Ivosidenib at a highly competitive price point, making it affordable and accessible for physicians, hospitals, and research facilities around the globe.

But it's not just about the quality and affordability of Ivosidenib that sets it apart from other treatment options. Our product is also backed by a wealth of clinical data and research, demonstrating its safety and efficacy in treating AML patients with IDH1 mutations. In clinical trials, Ivosidenib has shown the ability to induce complete remissions in many patients, with few adverse events and minimal side effects. This data is impressive and inspiring, and we are excited to share it with our merchant partners, who can in turn share it with their customers and patients.

We also understand the importance of education and training when it comes to selling and administering Ivosidenib. That's why we offer comprehensive training programs and materials for healthcare professionals and researchers who want to learn more about Ivosidenib and how to use it effectively. We believe that education is crucial to the success of any new therapy, and we are committed to providing the tools and resources that our partner merchants need to successfully market and promote Ivosidenib in their local markets.

Overall, we believe that Ivosidenib is a game-changing pharmaceutical that has the potential to revolutionize the treatment of AML patients with IDH1 mutations. With its unique chemical structure, selectivity, and proven efficacy, Ivosidenib stands out in a crowded marketplace and offers new hope for patients and their families. We are proud to manufacture and distribute this groundbreaking therapy, and we look forward to partnering with merchants around the world to help bring Ivosidenib to those who need it most.

Chemical Structure : Ivosidenib

CAS No.: 1448347-49-6

 

Ivosidenib(AG-120)

Catalog No.: URK-V690 Only Used For Lab.

A mutant-selective inhibitor of IDH1 (isocitrate dehydrogenase type 1).

Biological Activity

A mutant-selective inhibitor of IDH1 (isocitrate dehydrogenase type 1); represent a worthwhile avenue of exploration in the treatment of IDH1-mutated tumors.
Blood Cancer
Phase 3 Clinical

Physicochemical Properties

References

1. Cuyàs E, et al. Oncotarget. 2015 May 20;6(14):12279-96.

2. Cancer Discov. 2015 Jan;5(1):4.

URK-V690_COA

URK-V690_SDS

URK-V690_TDS

 

Note: All products of Ureiko are only used for scientific research or drug certificate declaration, and we do not provide products and services for any personal use!

Why choose us?

• Our Metabolic Enzyme/Protease Library products are stored under optimal conditions to maintain their effectiveness.
• We are committed to enhancing the social influence of our company and strive to innovate methods and carriers.
• Our Metabolic Enzyme/Protease Library products are available in a variety of sizes and formats to suit different applications.
• We always adhere to the business philosophy of "integrity as the cornerstone, customer as the axis, and quality to win the market".
• We are constantly researching and developing new and innovative Metabolic Enzyme/Protease Library products.
• Creating a first-class team is the guarantee of our target strategy and our core competitiveness.
• We use the latest equipment and technology in the production of our Metabolic Enzyme/Protease Library products.
• We strive to provide our customers with superior AG120,Ivosidenib CAS No.:1448347-49-6 and first-class services that can fully meet their requirements!
• We are a Chinese factory that specializes in providing high-quality Metabolic Enzyme/Protease Library products and services.
• Through the gradual establishment and improvement of an enterprising innovation strategy system with independent product research and development as the core competitiveness of the enterprise, we have now developed into a vane of industry technology research and development and an industry leader.

Hot Tags: ag120,ivosidenib cas no.:1448347-49-6, China ag120,ivosidenib cas no.:1448347-49-6, epigenetic library for epigenetic analysis of epigenetic dysregulation, agonists for drug metabolism, epigenetic library for epigenetic genotype, epigenetic library for epigenetic regulation of cell apoptosis, epigenetic library for epigenetic analysis of gene function, epigenetic library for epigenetic regulation of cell enhancement